Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic…more
Latest RNS from Convatec Group PLC
- buybackTransaction in Own Shares
- buybackTransaction in Own Shares
- board_changeNon-Executive Director appointment
- interim_resultsFurther re Interim results for first half of 2026
- interim_resultsInterim results for 6 months ended 30 June 2026
Analyst consensus: Buy
As of 23 Sept 2026, 19 analysts rate Convatec Group PLC a Buy, with 95% buy ratings and a mean price target of 305p (range 229p–373p), +42% vs the current price.
Valuation vs peers
Peer-relative fair value estimate: 188p against a current price of 216p (-13%), based on EV/EBITDA.